Autoantibody biomarkers for the detection of serous ovarian cancer

Highlights • Screened a total of 10,247 human antigens using customizable protein microarrays • Performed orthogonal ELISA assay to validate 39 candidate autoantibody biomarkers • Defined a panel of biomarkers with 45% sensitivity at > 99% specificity to screen for serous ovarian cancer

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2017-07, Vol.146 (1), p.129-136
Main Authors: Katchman, Benjamin A, Chowell, Diego, Wallstrom, Garrick, Vitonis, Allison F, LaBaer, Joshua, Cramer, Daniel W, Anderson, Karen S
Format: Article
Language:English
Subjects:
Antibodies, Neoplasm - blood
Antibodies, Neoplasm - immunology
Antigens, Neoplasm - blood
Antigens, Neoplasm - immunology
Autoantibodies - blood
Autoantibodies - immunology
Autoantibody
Biomarker
Biomarkers, Tumor - blood
Biomarkers, Tumor - immunology
Case-Control Studies
Cystadenocarcinoma, Serous - blood
Cystadenocarcinoma, Serous - immunology
Diagnostics
Female
Hematology, Oncology and Palliative Medicine
Humans
Middle Aged
Obstetrics and Gynecology
Ovarian cancer
Ovarian Neoplasms - blood
Ovarian Neoplasms - immunology
Protein Array Analysis
Proteomics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Screened a total of 10,247 human antigens using customizable protein microarrays • Performed orthogonal ELISA assay to validate 39 candidate autoantibody biomarkers • Defined a panel of biomarkers with 45% sensitivity at > 99% specificity to screen for serous ovarian cancer
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2017.04.005